People with diabetes face a higher risk for influenza and its complications. The diabetes community and ESWI therefore join forces to focus on the possible impact of influenza infection on diabetes patients and to discuss strategies to better protect them against the flu.
In its recently published paper (Vaccine Journal), ESWI has reviewed the scientific base for recommending routine vaccination of diabetes patients against influenza. Different studies indeed demonstrate that influenza infection tends to be more severe in diabetes patients and it may also cause complications like pneumonia, bronchitis, sinus infections and ear infections. As a matter of fact, diabetes triples the risk of hospitalization and quadruples the risk of intensive care unit admission once hospitalized for influenza. And yet, influenza vaccination rates in diabetes patients are generally low and well below WHO’s target of 75%
We therefore kindly invite the diabetes community – patient organizations, healthcare professionals and academic experts – to join us in the one-day symposium on influenza vaccination for diabetes patients. Through various lectures and a moderated audience debate, the colloquium aims to:
- review the scientific evidence that underpins vaccination recommendations for diabetes patients
- discuss the role in influenza prevention of organisations working with/for patients with diabetes
- explore pathways to raise flu awareness amongst patients and their environment